Fraunhofer Institute for Microengineering and Microsystems IMMImagine you could:
- assemble organ-on-chips (OoCs) reproducibly, one cell at time,
- generate consistent vascular networks down to the smallest capillaries,
- leverage TrapJet to leapfrog your competitors.
TrapJet: technology for reproducible Organs-on-Chips
Additive manufacturing with single-cell resolution
Minimize your risk of downstream failure in drug discovery.
Most frequently asked questions and answers:
What volumes are discharged from the microfluidic chip, per cell-encapsulating microdrop?
Volumes as low as 14 pL can be set using the nozzle size.
Has the survival rate of the cells been examined?
Yes, cells survive the printing process with a viability of 90%, which has been confirmed by fluorescence microsopy. The formation of a cell conglomerate (spheroid) with a predefined number of dispensed cells has been demonstrated.
What's new about the technology?
The technology continuously isolates cells from the supply- flow and temporarily stores them, allowing for on-demand dispensing through individual print-nozzles.
What print rates are planned for the future?
500 Hz!
What is the ORCAS principle, and why is it important?
The ORCAS principle combines the minimum requirements needed for successful single-cell printing with the long-term goal of organ printing. Our technology fulfils all five ORCAS criteria for the first time.
